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to disease-predisposing non-HLA genes (the linkage dis-
equilibrium [LD] model).
Although the association of two HLA-DR speciﬁcities
to MS is not inconsistent with any of the single-mech-
anism models mentioned above—it could be explained,
for example, by allelic heterogeneity (or even locus het-
erogeneity, given the extensive LD of the HLA region)—
at the same time, the contrasting modes of action of
DR15 and DR17 support an alternative, two-mechanism
model. Indeed, to explain the multiple HLA class II as-
sociations in rheumatoid arthritis, Zanelli et al. (2000)
have proposed such a model, involving both recessive
loss of immune protection and dominant exacerbation
of ongoing inﬂammation.
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Nuclear Factor TDP-43 Binds to the Polymorphic TG
Repeats in CFTR Intron 8 and Causes Skipping of
Exon 9: A Functional Link with Disease Penetrance
To the Editor:
In the January 2004 issue of AJHG, Groman et al. pub-
lished a collaborative study on the disease penetrance of
a common abbreviated tract of ﬁve thymidines (T5) in
intron 8 of the CFTR gene (MIM 602421). By analyzing
a large number of affected individuals presenting with
male infertility or nonclassical cystic ﬁbrosis (CF [MIM
219700]), they found that the pathogenic or benign ef-
fect of T5 correlated with variations in a TG repeat
sequence just upstream of the polypyrymidines. In par-
ticular, longer TG repeats (12 or 13) are associated with
disease phenotypes, and 91% of affected individuals, as
opposed to 22% of unaffected ones, have repetitions of
12 or 13 TGs. Although the modiﬁer effect of the TG
repeats on the T5 variant has been proposed elsewhere
(Cuppens et al. 1998), the principal novelty of the Gro-
man et al. study lies in the high number of patients
analyzed from different regions. As the T5 allele is found
in ∼10% of the general population, the results of this
study strongly indicate that determination of the TG
repeats may have a signiﬁcant diagnostic value.
The pathologies studied by Groman et al. are in line
with the growing number of human diseases resulting
from pre-mRNA splicing alterations and, speciﬁcally,
those diseases caused by mutations in cis-acting elements
(the TG and T repeats) that disrupt the use of alternative
splice sites, as recently reviewed by Faustino and Cooper
(2003). In this speciﬁc case, the pathogenetic role of
these repeats is owing to their effects on CFTR exon 9
at the level of pre-mRNA splicing, with longer UG re-
peats (and short U tracts) increasing exon 9 skipping
and leading to the production of a nonfunctional protein
(Delaney et al. 1993; Strong et al. 1993).
An obvious question, not taken into consideration in
the study by Groman et al., is what factor(s) or mech-
Figure 1 Interaction of UG repeats with TDP-43, causing splicing inhibition. A, Diagram of the in vitro splicing assay. Boxes indicate
exons, and the horizontal line indicates intronic sequences. In the UG6U5 construct, an A residue was removed in an attempt to keep the
distance to the branch point. This was not possible for UG8 and UG12, and the original CFTR 3′ splice site was maintained. All constructs
were transcribed by use of SP6 RNA polymerase and assayed with HeLa cells nuclear extracts (C4, Biotech) at time 0 hours and after 2 hours,
in accordance with standard protocols. Unprocessed and spliced RNAs (left) were resolved on 6% denaturing gels. B, Spliced RNAs, present
in the PY7(wt) and PY7(UG6U5) transcripts, reduced in the PY7(UG8U5) construct, and absent in PY7(UG12U5). C, Binding competition
analysis. Unlabeled (UG)12 RNA was added in a 10-fold molar excess to the splicing mix, successfully rescuing splicing in the PY7(UG12U5)
construct but having no effect on the PY7(wt) RNA. D, Western blot of normal (NE) and TDP-43 depleted (NE-TDP43) nuclear extracts. TDP-
43 is completely absent after depletion. E, Depletion of TDP-43 from the nuclear extract induces the appearance of the spliced form (lane NE-
TDP43) in the UG12-containing construct. The addition of puriﬁed GST-TDP-43 (300 ng) completely restores the splicing inhibition (lane NE-
TDP43 GST-TDP43).
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anism(s) determine the TG repeat number to be a reliable
predictor of penetrance for the T5 allele. Indeed, some
mechanisms have been proposed already, and, 12 years
ago, we reported that TDP-43 binds speciﬁcally to the
UG repeat sequence and, in this way, promotes skipping
of CFTR exon 9 (Buratti et al. 2001). In the same study,
overexpression of TDP-43 increased CFTR exon 9 skip-
ping in a minigene system, and ablation of its expression
by antisense oligonucleotides resulted in increased in-
clusion of the same exon. Moreover, TDP-43’s binding
to the UG repeat sequence has been shown to correlate
well with repeat length, and this has provided a clear
rationale as to why longer UG tracts determine a higher
rate of exon 9 skipping (Buratti and Baralle 2001). In
this respect, it may be worthwhile also to point out that
an independent and recent study conﬁrmed that the
mouse homologue of human TDP-43 (mTDP-43) also
inhibits human CFTR exon 9 splicing in a minigene sys-
tem (Wang et al. 2004).
To demonstrate that the UG–TDP-43 interactionplays
a direct role in splicing, we set up an in vitro splicing
assay, a useful system to deﬁne the details of the mo-
lecular mechanisms involved and the role played by in-
dividual splicing factors. To this end, we introduced dif-
ferent TG repeats followed by 5T in the 3′ splice site in
a heterologous context composed by two tropomyosin
exons separated by a 111-nt intron sequence (see boxed
sequences in ﬁg. 1A). In vitro analysis of the splicing
pattern of the transcribed RNA from these plasmids
shows that UG elements repress splicing. In fact, in-
creasing the number of UG repeats (UG6, UG8, andUG12)
results in progressive splicing inhibition (ﬁg. 1B). This
direct role of UG repeats in repressing splicing also can
be observed following the addition of an unlabeled
(UG)12 RNA competitor to the splicing mix: as shown
in ﬁgure 1C, this action can restore splicing activity of
the UG12U5 RNA. As a control, this ﬁgure also shows
that addition of cold (UG)12 RNA oligonucleotide does
not have any effect on the splicing of the PY7(wt) con-
struct (which does not contain any UG repeats) and that
the addition of equal amounts of a control 30-mer RNA
oligonucleotide has no effect on both the PY7(wt) and
the PY7(UG12U5) RNAs.
Having determined that (UG)12 sequences can pro-
mote splicing inhibition in vitro, we then checked
whether depletion of TDP-43 from the splicing mix (ﬁg.
1D) results in activation of splicing. Figure 1E shows
that, indeed, depletion of TDP-43 from the nuclear ex-
tract results in activation of splicing in the UG12U5
RNA, an activation that can be abolished in the depleted
extracts by the addition of recombinant TDP-43 (GST-
TDP43). In conclusion, all these results are consistent
with the model in which the TG repeats in the CFTR
intron 8 bind to TDP-43, and this protein, in turn, in-
hibits splicing of exon 9.
Taken together, our results provide not only a mech-
anistic explanation for the association data of Groman
et al. but also may provide a basis to explain the variable
phenotypic penetrance of the TG repeats. In fact, indi-
vidual and tissue-speciﬁc variability in the concentration
of this inhibitory splicing factor (Buratti et al. 2001) may
explain the not-yet-complete penetrance of the TG tract
in 22% of the unaffected individuals with the T5 variant
and a high TG number (Groman et al. 2004) and may
even represent one of the possible factors that determine
whether an individual will develop multisystemic (non-
classical CF) or monosymptomatic (CBAVD) disease.
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